Psilocybin Trial in Veterans With Treatment-Resistant PTSD Reports 75% Remission at One Month

Nine of twelve veterans with severe, treatment-resistant PTSD no longer met diagnostic criteria a month after two doses of psilocybin. The trial was designed to test safety, not efficacy, and the most interesting result showed up before anyone took a capsule.